SE8204792L - N-metyl-d-glukaminsalt av 3,4-dihydro-5-metyl-6-(2-metyl-propyl)-4-oxotieno(2,3-d)pyrimidin-2-karboxylsyra och farmaceutisk komposition innehallande detta salt - Google Patents

N-metyl-d-glukaminsalt av 3,4-dihydro-5-metyl-6-(2-metyl-propyl)-4-oxotieno(2,3-d)pyrimidin-2-karboxylsyra och farmaceutisk komposition innehallande detta salt

Info

Publication number
SE8204792L
SE8204792L SE8204792A SE8204792A SE8204792L SE 8204792 L SE8204792 L SE 8204792L SE 8204792 A SE8204792 A SE 8204792A SE 8204792 A SE8204792 A SE 8204792A SE 8204792 L SE8204792 L SE 8204792L
Authority
SE
Sweden
Prior art keywords
methyl
salt
dihydro
carboxylic acid
glucamine
Prior art date
Application number
SE8204792A
Other languages
English (en)
Other versions
SE453504B (sv
SE8204792D0 (sv
Inventor
A A Larsen
D A Owens
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of SE8204792D0 publication Critical patent/SE8204792D0/sv
Publication of SE8204792L publication Critical patent/SE8204792L/sv
Publication of SE453504B publication Critical patent/SE453504B/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/16Otologicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicinal Preparation (AREA)
SE8204792A 1981-08-21 1982-08-20 N-metyl-d-glukaminsalt av 3,4-dihydro-5-metyl-6-(2-metylpropyl)-4-oxotieno(2,3-d)-pyrimidin-2-karboxylsyra och farmaceutisk komposition innehallande detta salt SE453504B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/294,962 US4377583A (en) 1981-08-21 1981-08-21 N-Methyl-D-glucamine salt of with 3,4-dihydro-5-methyl-6-(2-methylpropyl)-4-oxothieno[2,3-d]pyrimidine-2-carboxylic acid

Publications (3)

Publication Number Publication Date
SE8204792D0 SE8204792D0 (sv) 1982-08-20
SE8204792L true SE8204792L (sv) 1983-02-22
SE453504B SE453504B (sv) 1988-02-08

Family

ID=23135663

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8204792A SE453504B (sv) 1981-08-21 1982-08-20 N-metyl-d-glukaminsalt av 3,4-dihydro-5-metyl-6-(2-metylpropyl)-4-oxotieno(2,3-d)-pyrimidin-2-karboxylsyra och farmaceutisk komposition innehallande detta salt

Country Status (23)

Country Link
US (1) US4377583A (sv)
JP (1) JPS5843976A (sv)
KR (1) KR870001240B1 (sv)
AT (1) AT381314B (sv)
AU (1) AU558004B2 (sv)
BE (1) BE894162A (sv)
CA (1) CA1224465A (sv)
CH (1) CH651569A5 (sv)
DE (1) DE3231103A1 (sv)
DK (1) DK164059C (sv)
ES (1) ES515156A0 (sv)
FI (1) FI74965C (sv)
FR (1) FR2511680B1 (sv)
GB (1) GB2104521B (sv)
GR (1) GR76250B (sv)
IE (1) IE53804B1 (sv)
IT (1) IT1149064B (sv)
LU (1) LU84346A1 (sv)
MY (1) MY8800122A (sv)
NL (1) NL8203280A (sv)
PT (1) PT75446A (sv)
SE (1) SE453504B (sv)
ZA (1) ZA826019B (sv)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5753701A (en) * 1996-10-25 1998-05-19 University Of Kentucky N-chloro-N-methyl glucamine and N-chloro-N-methyl glucamine esters as novel safe agents for water disinfection
JP2007529544A (ja) * 2004-03-17 2007-10-25 パナコス ファーマシューティカルズ, インコーポレイテッド 3−o−(3’,3’−ジメチルスクシニル)ベツリン酸の製薬的な塩
US11571431B2 (en) * 2013-12-04 2023-02-07 Galmed Research And Development Ltd Aramchol salts
MX2020010884A (es) * 2018-04-17 2021-02-26 Cardurion Pharmaceuticals Llc Sales de meglumina de tienopirimidinas.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4054656A (en) * 1975-09-10 1977-10-18 Mead Johnson & Company Thieno[2,3-d]pyrimidine antiallergic agents

Also Published As

Publication number Publication date
JPH0476995B2 (sv) 1992-12-07
DK164059B (da) 1992-05-04
FI822907L (fi) 1983-02-22
DK164059C (da) 1992-09-28
DE3231103C2 (sv) 1990-10-04
IT8249006A0 (it) 1982-08-19
KR840001178A (ko) 1984-03-28
ZA826019B (en) 1983-07-27
US4377583A (en) 1983-03-22
ATA318382A (de) 1986-02-15
CH651569A5 (de) 1985-09-30
ES8401074A1 (es) 1983-12-01
AU558004B2 (en) 1987-01-15
SE453504B (sv) 1988-02-08
FI74965C (sv) 1988-04-11
FI74965B (fi) 1987-12-31
GB2104521B (en) 1985-05-22
IE53804B1 (en) 1989-03-01
AU8743082A (en) 1983-02-24
PT75446A (en) 1982-09-01
FR2511680B1 (fr) 1985-12-27
NL8203280A (nl) 1983-03-16
DK372282A (da) 1983-02-22
GR76250B (sv) 1984-08-04
JPS5843976A (ja) 1983-03-14
SE8204792D0 (sv) 1982-08-20
LU84346A1 (fr) 1983-06-07
CA1224465A (en) 1987-07-21
KR870001240B1 (ko) 1987-06-26
MY8800122A (en) 1988-12-31
ES515156A0 (es) 1983-12-01
FR2511680A1 (fr) 1983-02-25
IT1149064B (it) 1986-12-03
FI822907A0 (fi) 1982-08-20
AT381314B (de) 1986-09-25
IE822017L (en) 1983-02-21
DE3231103A1 (de) 1983-03-10
BE894162A (fr) 1983-02-21
GB2104521A (en) 1983-03-09

Similar Documents

Publication Publication Date Title
IT1207994B (it) Sali idrosulubili di composti adattivita' antiinfiammatoria ed analgesica, loro preparazione ed utilizzo in composizioni farmaceutiche.
ATE71375T1 (de) Substituierte 6-fluor-4-oxo-1,4-dihydrochinolin-3-carbonsaeure ; deren derivate; diese verbindung enthaltende pharmazeutische zubereitungen und verfahren zur herstellung dieser verbindungen.
SE7903817L (sv) Moranolinderivat
DK0598770T3 (da) Pyrazinderivater samt fremstilling og anvendelse deraf
FR2392971A1 (fr) Derives de l'acide prostanoique, leur preparation et medicament contenant ces substances
FR2407928A1 (fr) Derives de quinazoline utiles comme medicaments antihypertenseurs et procede de leur preparation
DE3688087D1 (de) Cephemverbindungen, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische praeparate.
ZA836663B (en) Isoquinoline derivatives,a process for their preparation,pharmaceutical formulations based on these compounds and the use thereof
SE8204792D0 (sv) N-metyl-d-glukaminsalt av 3,4-dihydro-5-metyl-6-(2-metyl-propyl)-4-oxotieno(2,3-d)pyrimidin-2-karboxylsyra och farmaceutisk komposition innehallande detta salt
AU530678B2 (en) Phosphono-hydroxy-acetic acid
FI903692A0 (fi) Salter av n5, n10-metylen-5,6,7,8- tetrahydrofolsyra.
MX9302711A (es) Preparacion de base.
SE8004383L (sv) Farmaceutisk beredning for oral administrering och forfarande for dess framstellning
NZ220800A (en) Tetrahydrobenzothiazoles and pharmaceutical compositions
ATE1442T1 (de) Pharmazeutisches mittel, enthaltend all-e- oder 13-z-7,8-dehydro-retinsaeure und verfahren zu seiner herstellung.
ATE4808T1 (de) Piperidinderivate von 3-hydroxy-thiophen-2carbons[ureestern,ihre herstellung und diese enthaltende pharmazeutische zubereitungen.
SE7902817L (sv) Substituerade /4h/ 1,3-bensodioxin-2-karboxylsyraderivat, framstellning och anvendning derav sasom lekemedel samt farmaceutiska kompositioner innehallande dessa
JPS5219647A (en) Preparation of 3-aminomethyl-4- homoisotwistane and its acid addition salt
JPS56110614A (en) External anti-inflammatory and analgesic drug
TH2131B (th) การเตรียมอนุพันธ์ของเบนซิมิดาโซลและสารผสมของสารเหล่านี้
TH893A (th) การเตรียมอนุพันธ์ของเบนซิมิดาโซลและสารผสมของสารเหล่านี้
TH364A (th) สารประกอบชนิดใหม่ซึ่งมีประโยชน์ในการรักษาโรค(กรรมวิธี)
ES2019885B3 (es) Sal sodica del acido etodolico y procedimiento para su preparacion.
FR2289201A1 (fr) Derives de l'acide pregnanoique-21 utilisables comme substances actives de medicaments

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8204792-9

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8204792-9

Format of ref document f/p: F